These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24418878)

  • 21. Dioscorea Extract (DA-9801) Modulates Markers of Peripheral Neuropathy in Type 2 Diabetic db/db Mice.
    Moon E; Lee SO; Kang TH; Kim HJ; Choi SZ; Son MW; Kim SY
    Biomol Ther (Seoul); 2014 Sep; 22(5):445-52. PubMed ID: 25414776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy.
    Hernández-Pedro N; Ordóñez G; Ortiz-Plata A; Palencia-Hernández G; García-Ulloa AC; Flores-Estrada D; Sotelo J; Arrieta O
    Transl Res; 2008 Jul; 152(1):31-7. PubMed ID: 18593635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treadmill training combined with insulin suppresses diabetic nerve pain and cytokines in rat sciatic nerve.
    Chen YW; Chiu CC; Hsieh PL; Hung CH; Wang JJ
    Anesth Analg; 2015 Jul; 121(1):239-246. PubMed ID: 25993391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
    Obrosova IG; Fathallah L; Stevens MJ
    Exp Neurol; 2001 Nov; 172(1):211-9. PubMed ID: 11681853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Adjusting internal organs and dredging channel" electroacupuncture treatment prevents the development of diabetic peripheral neuropathy by downregulating glucose-related protein 78 (GRP78) and caspase-12 in streptozotocin-diabetic rats.
    Pan H; Huang H; Zhang L; Ma S; Yang H; Wang H
    J Diabetes; 2019 Dec; 11(12):928-937. PubMed ID: 30884162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Date fruit extract is a neuroprotective agent in diabetic peripheral neuropathy in streptozotocin-induced diabetic rats: a multimodal analysis.
    Zangiabadi N; Asadi-Shekaari M; Sheibani V; Jafari M; Shabani M; Asadi AR; Tajadini H; Jarahi M
    Oxid Med Cell Longev; 2011; 2011():976948. PubMed ID: 22191015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment.
    Renno WM; Saleh F; Klepacek I; Al-Awadi F
    Medicina (Kaunas); 2006; 42(2):147-63. PubMed ID: 16528132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
    Yadav SK; Nagori BP; Desai PK
    J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy.
    Pesaresi M; Giatti S; Cavaletti G; Abbiati F; Calabrese D; Lombardi R; Bianchi R; Lauria G; Caruso D; Garcia-Segura LM; Melcangi RC
    Neuroscience; 2011 Dec; 199():401-9. PubMed ID: 21945035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats.
    Pesaresi M; Maschi O; Giatti S; Garcia-Segura LM; Caruso D; Melcangi RC
    Horm Behav; 2010 Jan; 57(1):46-55. PubMed ID: 19422828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
    Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin.
    Alp H; Varol S; Celik MM; Altas M; Evliyaoglu O; Tokgoz O; Tanrıverdi MH; Uzar E
    Exp Diabetes Res; 2012; 2012():230342. PubMed ID: 22291696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
    Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
    Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
    Tiwari V; Kuhad A; Chopra K
    Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.
    Samii A; Unger J; Lange W
    Neurosci Lett; 1999 Mar; 262(3):159-62. PubMed ID: 10218880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild ischemia causes severe pathological changes in experimental diabetic nerve.
    Nukada H
    Muscle Nerve; 1992 Oct; 15(10):1116-22. PubMed ID: 1406769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats.
    Jin HY; Lee KA; Wu JZ; Baek HS; Park TS
    Endocrine; 2014 Dec; 47(3):772-82. PubMed ID: 24532138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.
    Sandireddy R; Yerra VG; Komirishetti P; Areti A; Kumar A
    Cell Mol Neurobiol; 2016 Aug; 36(6):883-892. PubMed ID: 26399251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy.
    Cermenati G; Giatti S; Cavaletti G; Bianchi R; Maschi O; Pesaresi M; Abbiati F; Volonterio A; Saez E; Caruso D; Melcangi RC; Mitro N
    J Neurosci; 2010 Sep; 30(36):11896-901. PubMed ID: 20826654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat.
    Liu WJ; Jin HY; Park JH; Baek HS; Park TS
    Eur J Pharmacol; 2010 Jul; 637(1-3):70-6. PubMed ID: 20406631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.